[An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
Two of the persisting controversies concerning malignant hyperthermia (MH) are discussed: storing and dosage of dantrolene and preoperative tactics to be followed with patients who are MH-susceptible. Reasons are presented for the obligation to store sufficient amounts of dantrolene in every operating suite. The second part discusses the question of pretreatment of MH-susceptible patients with dantrolene.
Schulte-Sasse
U
U
Klinik für Anaesthesie und Operative Intensivmedizin, Städtisches Krankenhaus Heilbronn, Akademisches Lehrkrankenhaus, Universität Heidelberg.
Eberlein
H J
HJ
D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use*; D004198:Disease Susceptibility; D006801:Humans; D008305:Malignant Hyperthermia / Q000517:prevention & control / Q000628:therapy*; D011300:Preoperative Care
D003620:Dantrolene
Ein Beitrag zur Beseitigung von Meinungsverschiedenheiten auf dem Gebiet der Malignen Hyperthermie.